The main role of the Thai FDA is to protect consumers’ health, especially, to ensure safety, quality and efficacy of health products within its remit. These include: foods, drugs, psychotropic substances, narcotics, medical devices, volatile substances, cosmetics and hazardous substances available in the country. This has to be implemented in accordance with national legislation and international agreements as follows:
Drug Act, B.E. 2510 (1967)
Psychotropic Substances Act B.E. 2518 (1975)
Food Act, B.E. 2522 (1979)
Narcotics Act, B.E. 2522 (1979)
Medical Devices Act, B.E. 2531 (1988)
The Emergency Decree on Prevention of Abuse of Volatile Substances, B.E. 2533 (1990)
Cosmetics Act, B.E. 2535 (1992)
Hazardous Substances Act, B.E. 2535 (1992)
The Single Convention on Narcotic Drugs 1961, commentary on the protocol amended in Geneva on March 25, 1972.
The International Convention on Psychotropic Substances, 1971.
The International Code on Marketing of Breast Milk Substitute, 1981
The United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988.
By law, certain important issues are decided by committees, whose members, all experts in their fields, are appointed by the Minister of Public Health. Currently, there are six committees : Drugs, Food, Cosmetics, Narcotics, Psychotropic Substances and Medical Devices.
There are two committees whose members are appointed by the other ministries. They are the Committee on the Prevention of Abuse of Volatile Substances appointed by two ministers (Industry and Public Health), and the Hazardous Substance Committee appointed by three ministers (Public Health, Industry and Agriculture).
At the national level, the Cabinet appoints three committees: the National Drug Committee, the National Food Committee and the National Chemical Safety Committee. The national committees are mainly assigned policy and development issues and collaborative action with other agencies to facilitate the implementation of the food, drug and chemical safety program as well as the control system.
Rajan Kalidindi, Country Manager for GE Healthcare Thailand, elaborates on the innovative solutions which drive delivery of care and reduce operational inefficiencies and costs that the affiliate brings to Thailand…
The Pharmaceutical Research and Manufacturers Association (PReMA) has been a key stakeholder in promoting the value of innovation in Thailand for over 100 years. CEO Dr Busakorn Lerswatanasivalee discusses the…
Selim Sezgin, country manager and managing director of Pfizer Thailand, highlights the recent transformation of the affiliate to adapt to Thailand’s changing climate, as well as the vision of Pfizer…
Sayan Roy, managing director of B. Braun Thailand, highlights the importance of the group’s 2020 Vision “Growing Together” and how the affiliate is carrying this out locally to be a…
Anutin Charnvirakul, recently appointed deputy prime minister and minister of public health of Thailand, shares his initial priorities since taking on the role in July 2019. Charnvirakul then goes on…
As Thailand’s focus has shifted towards R&D over the past few years, the number of in-country clinical trials being conducted has increased concurrently. From 2011 to 2016, Thailand conducted a…
Suchart Chookruvong and Wanna Thanesanont of Thai generics player Polipharm, highlight the growing importance of R&D within their strategy, how the firm has remained focused on quality, and why Polipharm…
Riaz Buksh, general manager of Bayer’s Pharmaceuticals Division in Thailand, Cambodia, Myanmar, and Laos, highlights the importance of the mission “Science for a Better Life” and innovation in the affiliate,…
Kevin Peters, Managing Director of MSD in Thailand, highlights the strategic significance and strong performance of the affiliate as a top three pharmaceutical player in Thailand. Kevin goes on to…
Kris Sisneros, managing director of Merck Thailand highlights the importance of going beyond therapeutic areas and caring about the Thai people, the patient and the people in the company. He…
Thailand is known around the world for its lush landscapes, ancient architecture and breathtaking beaches. The nation receives more than 35 million visitors each year. Thailand ranked 4th globally for…
Suthep Namwongsamran, GM of M&H Manufacturing, provides insights into the distinctive model that has allowed M&H to become one of Thailand’s leading domestic pharmaceutical manufacturers. He also outlines the expected…